Breathe Well Live Well
|
Research and Markets: Roche/Genentech/Novartis' Asthma Treatment – Xolair …
Business Wire (press release) Roche/Genentech/Novartis' Xolair (omalizumab) is currently the only FDA-approved biologic used in the treatment of asthma. This drug is a recombinant humanized mAb that binds and neutralizes IgE with the same high affinity as its cognate receptor, FceRI. Research and Markets: Merck's Dulera Asthma Treatment – Forecast and Market … |
View full post on asthma – Google News
|
Karlovy Vary Review: Jake Hoffman's Directorial Debut 'Asthma' With Krysten …
Indie Wire (blog) Really, it's a win/win situation. If the logline “examines the consequences of the 'live fast, die young' mentality in New York's indie rock scene” doesn't chill you to your core, perhaps you might actually get something out of “Asthma,” the … |
View full post on asthma – Google News
|
Research and Markets: Italy Asthma Market Highlights – 2014
Business Wire (press release) The latest research, 'Italy Asthma Market Highlights – 2014', provides Italy asthma market analysis, competitive landscape, and asthma drug sales forecast in Italy. The research includes Italy asthma market size estimates for 2013, market share … |
View full post on asthma – Google News
|
Research and Markets: Europeab Asthma Market Highlights – 2014 Report
Business Wire (press release) The latest research, 'Europe Asthma Market Highlights – 2014', provides asthma market analysis, competitive landscape, and asthma drug sales forecast for Germany, France, Italy, Spain, and UK. The research includes Europe (Germany, France, Italy, Spain … Research and Markets: Japan Asthma Market Report 2014-2019 |
View full post on asthma – Google News
|
Wellapets by LifeGuard Games, Inc: Virtual Pets Make Asthma Something To …
Business Wire (press release) BOSTON–(BUSINESS WIRE)–When asthma affects kids, it affects entire families. For over 6 million US kids and families, asthma can imply stress, fear and stigma. Emergency room visits scare everyone! Alex Ryu wanted to address this, so he left Harvard … |
View full post on asthma – Google News
|
ASTHMA: New Phase III data show tiotropium * Respimat ® effective across …
Business Wire (press release) Boehringer Ingelheim today announced new data from large scale, Phase III studies showing that once-daily tiotropium delivered via the Respimat® inhaler was effective and well tolerated in patients across asthma severities. These data were presented at … |
View full post on asthma – Google News
|
Research and Markets: Global Asthma Pipeline Highlights – 2014
Business Wire (press release) The latest report Asthma Pipeline Highlights – 2014, provides most up-to-date information on key pipeline molecules in the global asthma market. It covers emerging therapies for asthma in active clinical development stages including early and late … |
View full post on asthma – Google News
|
Prevent Asthma and Allergies Triggered by Pests This Spring
Business Wire (press release) FAIRFAX, Va.–(BUSINESS WIRE)–Every year, the Asthma and Allergy Foundation of America designates May as National Asthma and Allergy Awareness Month, a peak season for allergy and asthma symptoms. The National Pest Management Association … Study offers hope for allergy sufferers that don't like shots in doctor's office |
View full post on asthma – Google News
|
Prevent Asthma and Allergies Triggered by Pests This Spring
Business Wire (press release) FAIRFAX, Va.–(BUSINESS WIRE)–Every year, the Asthma and Allergy Foundation of America designates May as National Asthma and Allergy Awareness Month, a peak season for allergy and asthma symptoms. The National Pest Management Association … Study offers hope for allergy sufferers that don't like shots in doctor's office |
View full post on asthma – Google News
|
Phase III results: tiotropium* Respimat® is effective in symptomatic asthma …
Business Wire (press release) SAN ANTONIO, Texas–(BUSINESS WIRE)–Tiotropium delivered once daily via Respimat™ significantly improved lung function and reduced asthma exacerbations in patients who remain symptomatic despite treatment with at least ICS†/LABA‡, irrespective … Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic … |
View full post on asthma – Google News